Meet our doctors Last reviewed: 19 Jun 2026 Sources Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes (1998) PubMed [accessed 21 October 2025] Wegovy dosing schedule (2024) Wegovy.com [accessed 21 October 2025] Wegovy (semaglutide): a new weight loss drug for chronic weight management (2022) BMJ [accessed 21 October 2025] Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen (2023) EMC [accessed 13 January 2026] Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes, The New England Journal of Medicine [accessed 21 October 2025] Weight loss injections NHS weight loss injections GLP-1 for weight loss Can doctors help with weight loss
From there, they can develop a personalized risk assessment to determine whether non-hormonal options, such as GLP-1 medications, might be appropriate for you
My goal was to drink at least 64 ounces daily
Regular monitoring may be appropriate for patients with chronic conditions, ensuring stability and detecting any disease progression
This pathway primarily influences insulin secretion and glucagon inhibition in pancreatic beta and alpha cells, respectively
We see professionals who feel drained after long weeks, parents who want more consistent energy, and active adults who notice that recovery and focus are not what they used to be